✦ LIBER ✦

Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck : A Phase II trial

✍ Scribed by John C. Grecula; Roy E. Smith; Chris A. Rhoades; Pramod Sharma; Amit Agrawal; Hong Zhang; James Allen; Federico P. Goldman; Donn Young; David E. Schuller

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 113 KB
Volume: 89
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20001215)89:12<2587::aid-cncr11>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of adriamycin in previo

A phase II study of adriamycin in previously untreated squamous cell carcinoma of the head and neck

✍ Melody A. Cobleigh; James H. Hill; Patricia A. Gallagher; Lawrence J. Kukla; Tho 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 2 views

Twenty patients with squamous cell carcinoma of the head and neck (SCC H/N) were treated with Adriamycin (doxorubicin) at a dosage of 60 mg/m\* at 3-week intervals. No patient had received surgery, radiation, or chemotherapy before treatment with Adriamycin. Responses were observed in 44% of 18 eval

Phase II evaluation of paclitaxel in com

Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma

✍ Joseph I. Clark; Craig Hofmeister; Abdul Choudhury; Gregory Matz; Sharon Collins 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

Phase II study of paclitaxel, ifosfamide

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma

✍ Dong M. Shin; Fadlo R. Khuri; Bonnie S. Glisson; Lawrence Ginsberg; Vali M. Papa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Final report of a phase II evaluation of

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck : An Eastern Cooperative Oncology Group trial (PA390)

✍ Arlene A. Forastiere; Darleen Shank; Donna Neuberg; Samuel G. Taylor IV; Ronald 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.

A phase II study of piritrexim in patien

A phase II study of piritrexim in patients with advanced squamous head and neck cancer

✍ Wu-Ching Uen; Andrew T. Huang; Robert Mennel; Stephen E. Jones; Monica B. Spauld 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the

Vinorelbine, cisplatin, and 5-fluorourac

Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck : Results of a Phase II multicenter study

✍ Vittorio Gebbia; Glovanni Mantovani; Antonio Farris; Biagio Agostara; Alberto De 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## BACKGROUND. The combination of vinorelbine (VNR), cisplatin (CDDP), and 5-fluoro-